immunity News and Research

RSS

Differences in blood gene expression among patients with varying COVID-19 severity

A new study published on the medRxiv* pre-print server and currently undergoing peer-review aims to answer this question through whole blood transcriptomics of individuals with varying degrees of COVID-19 severity. Transcriptomics, done by RNA sequencing, gives insights into the genes expressed in a cell at a given time point. It gives an analysis of all RNA molecules within a cell, in this case, whole blood.

23 Sep 2021

The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy

In a paper, the vaccine-induced cellular and immune response of MS patients receiving a range of therapies are assessed.

23 Sep 2021

Antibody kinetics in recovered COVID-19 patients

Researchers from Tel Aviv University have been examining the kinetics of antibodies in recovered COVID-19 patients.

23 Sep 2021

U.S. vaccination effort against COVID-19 needs intensifying, warn researchers

Researchers have warned that the United States has not yet reached the necessary thresholds for achieving population immunity against severe acute respiratory coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

22 Sep 2021

Researchers encourage longer dosing intervals for Pfizer-BioNTech’s COVID-19 vaccine

Researchers in Canada, Italy, and the United States have encouraged extending the interval time between two doses of Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine among individuals who have not previously been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

22 Sep 2021

Bluetooth-based contact-tracing apps could enhance vaccine strategies

Mathematical modeling of disease spread suggests that herd immunity could be achieved with fewer vaccine doses by using Bluetooth-based contact-tracing apps to identify people who have more exposure to others-;and targeting them for vaccination.

22 Sep 2021

Pregnant women who receive COVID-19 vaccine pass high levels of antibodies to their babies

Women who receive the mRNA COVID-19 vaccine during pregnancy pass high levels of antibodies to their babies, a new study finds.

22 Sep 2021

COVID-19 will become a seasonal disease, U-M epidemiologist says

A University of Michigan epidemiologist believes that COVID-19 will become a seasonal disease, likely in the fall and winter seasons.

22 Sep 2021

mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

Scientists from the USA have recently compared the dynamics of humoral and cellular immune responses induced by mRNA-based and adenoviral vector-based coronavirus disease 2019 (COVID-19) vaccines. The findings reveal a difference in humoral immune responses. The study is currently available on the medRxiv* preprint server.

22 Sep 2021

Will ‘Dr. Disinformation’ ever face the music?

Earlier this month, Dr. Rashid Buttar posted on Twitter that covid-19 "was a planned operation" and shared an article alleging that most people who got the covid vaccine would be dead by 2025.

22 Sep 2021

Unique tiny Ilamas antibodies could be used for treatment of COVID-19

A unique type of tiny antibody produced by llamas could provide a new frontline treatment against Covid-19 that can be taken by patients as a simple nasal spray.

22 Sep 2021

Consumption of common antibiotic during pregnancy can reduce low birth weight and premature births

A common antibiotic has been found to reduce low birth weight and premature births, if taken during pregnancy, in countries where malaria is endemic, according to a research review.

22 Sep 2021

New framework needed to explore links between evolved pathogen tolerance and emerging infections

A new multidisciplinary research framework is needed to explore links between evolved tolerance to pathogens and their spillover into humans, scientists write today in the journal eLife.

22 Sep 2021

COVID-19 deaths in U.S. surpass 1918 Spanish Flu pandemic

The coronavirus disease (COVID-19) pandemic is most likely the deadliest outbreak in recent American history, exceeding the estimated deaths from the 1918 influenza pandemic.

21 Sep 2021

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Researchers recently investigated the effect of infection with SARS-CoV-2 in patients with hematologic malignancies in minority populations.

21 Sep 2021

Scientists identify potential therapeutic targets to alleviate severe COVID-19 in aged patients

The scientists assessed epidemiological data from March to December 2020 from the CDC to investigate the prevalence of COVID-19 disease among different age groups.

21 Sep 2021

Three US COVID-19 vaccines provide substantial protection against hospitalization

A new study reports that a head-to-head comparison of the efficacy of the three vaccines used in the USA indicates substantial protection against hospitalization with COVID-19 following vaccination with any of these vaccines.

21 Sep 2021

Maintenance dialysis patients may need additional shots of COVID-19 vaccines

Researchers in the United States have conducted a study showing that the antibody response to vaccination designed to protect against coronavirus disease 2019 (COVID-19) wanes substantially over time among patients receiving maintenance dialysis.

21 Sep 2021

COVID-19 vaccine effectiveness against SARS-CoV-2 variants

A commentary published in the journal Cell summarizes international data on vaccine effectiveness against new severe acute respiratory coronavirus 2 (SARS-CoV-2) variants. Evidence shows that the currently approved vaccines continue to be effective in preventing severe and symptomatic illness — even with the widely circulating Delta variant.

21 Sep 2021

Scientists hypothesize SARS-CoV-2 cryptically circulating among humans before the current outbreak

As nations begin to recover, researchers from the National Taiwan University and Academia Sinica in Taipei have been looking to identify the changes the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) underwent over the course of the pandemic in order to better understand why the disease showed such virulence.

20 Sep 2021

immunity News and Research

Differences in blood gene expression among patients with varying COVID-19 severity

The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy

Antibody kinetics in recovered COVID-19 patients

U.S. vaccination effort against COVID-19 needs intensifying, warn researchers

Researchers encourage longer dosing intervals for Pfizer-BioNTech’s COVID-19 vaccine

Bluetooth-based contact-tracing apps could enhance vaccine strategies

Pregnant women who receive COVID-19 vaccine pass high levels of antibodies to their babies

COVID-19 will become a seasonal disease, U-M epidemiologist says

mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

Will ‘Dr. Disinformation’ ever face the music?

Unique tiny Ilamas antibodies could be used for treatment of COVID-19

Consumption of common antibiotic during pregnancy can reduce low birth weight and premature births

New framework needed to explore links between evolved pathogen tolerance and emerging infections

COVID-19 deaths in U.S. surpass 1918 Spanish Flu pandemic

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Scientists identify potential therapeutic targets to alleviate severe COVID-19 in aged patients

Three US COVID-19 vaccines provide substantial protection against hospitalization

Maintenance dialysis patients may need additional shots of COVID-19 vaccines

COVID-19 vaccine effectiveness against SARS-CoV-2 variants

Scientists hypothesize SARS-CoV-2 cryptically circulating among humans before the current outbreak

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News